久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Innovation

Chinese HEV vaccine begins clinical trial in US

Xinhua | Updated: 2019-05-04 16:13
Share
Share - WeChat
[Photo/VCG]

XIAMEN - A Chinese vaccine against the Hepatitis E Virus (HEV) has entered clinical trial in the United States after two US volunteers were vaccinated on May 1 (local time), according to Xiamen University.

The trial will be carried out in three phases. The phase 1 clinical trial is scheduled to enroll 25 US volunteers, and Phase 2 and 3 FDA-approved trials of the vaccine are expected to be done in a third country.

The vaccine, sold under the trade name Hecolin, was initially developed by a research team from Xiamen University in East China's Fujian province and then transferred to and commercialized by the Xiamen Innovax Biotech Co., Ltd.

Hecolin has been used in China since 2012 for the prevention of hepatitis E.

It has been approved by the US Food and Drug Administration (FDA) to enter a clinical trial in January.

It is the first time that FDA has given a green light to a Chinese vaccine to enter a clinical trial in the United States, according to Zhang Jun, deputy director of National Institute of Diagnostics and Vaccine Development in Infectious Diseases at Xiamen University.

According to Zhang, the trial was sponsored by the National Institutes of Health (NIH), the primary agency of the US government responsible for biomedical and public health research.

Hepatitis E is a liver disease caused by HEV, which is transmitted mainly through contaminated drinking water and food. Large outbreaks of the disease have been reported in at least 30 countries in Africa, Asia and North America.

According to a World Health Organization (WHO) report in 2015, there are approximately 20 million HEV infections, 3.4 million symptomatic cases and 70,000 deaths globally every year.

The disease is typically most life-threatening among pregnant women, with a fatality rate of 10 percent to 50 percent. People with pre-existing chronic liver disease are prone to develop severe hepatitis following HEV infection.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 午夜成年女人毛片免费观看 | 一级毛片视频播放 | 免费一级特黄3大片视频 | 免费a级毛片网站 | 亚洲精品影院久久久久久 | 久青草国产手机在线观 | www.91成人| 欧美成人午夜视频免看 | 手机看片日韩国产一区二区 | 久在草 | 玖玖99视频 | 久久国产精品-久久精品 | 一区二区伦理 | 日韩久久精品 | 大臿蕉香蕉大视频成人 | 中文字幕免费观看 | 欧美三级欧美一级 | 国产亚洲精品成人婷婷久久小说 | 欧美成人香蕉网在线观看 | 自拍视频一区 | 国产一级特黄全黄毛片 | 成人午夜免费观看 | 怡红院视频网 | 老人久久www免费人成看片 | 国产一二三区在线观看 | 国产精品v免费视频 | 午夜在线观看视频免费 成人 | 窝窝女人体国产午夜视频 | 日韩欧美不卡在线 | 欧美人成在线 | 人成午夜性刺激免费 | 男女性关系视频免费观看软件 | 国产高清在线精品一区二区 | 日韩精品中文字幕一区三区 | 国产在亚洲线视频观看 | 国产99视频精品免费视频免里 | 中文字幕在线观看一区 | 亚洲国产日韩a在线亚洲 | 香蕉成人国产精品免费看网站 | 九九精品国产兔费观看久久 | 亚洲国产精品成人综合久久久 |